ES415611A1 - Un procedimiento para preparar una prostaglandina. - Google Patents

Un procedimiento para preparar una prostaglandina.

Info

Publication number
ES415611A1
ES415611A1 ES415611A ES415611A ES415611A1 ES 415611 A1 ES415611 A1 ES 415611A1 ES 415611 A ES415611 A ES 415611A ES 415611 A ES415611 A ES 415611A ES 415611 A1 ES415611 A1 ES 415611A1
Authority
ES
Spain
Prior art keywords
carbon atoms
see formula
substituted
arioyl
tetrahydropyranyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES415611A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES415611A1 publication Critical patent/ES415611A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
ES415611A 1972-06-07 1973-06-06 Un procedimiento para preparar una prostaglandina. Expired ES415611A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26051872A 1972-06-07 1972-06-07

Publications (1)

Publication Number Publication Date
ES415611A1 true ES415611A1 (es) 1976-07-16

Family

ID=22989486

Family Applications (3)

Application Number Title Priority Date Filing Date
ES415611A Expired ES415611A1 (es) 1972-06-07 1973-06-06 Un procedimiento para preparar una prostaglandina.
ES430417A Expired ES430417A1 (es) 1972-06-07 1974-09-26 Procedimiento para preparar bromuro de amidoalquil-trifenil-fosfonio.
ES430416A Expired ES430416A1 (es) 1972-06-07 1974-09-26 Procedimiento para preparar derivados de prostaglandina.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES430417A Expired ES430417A1 (es) 1972-06-07 1974-09-26 Procedimiento para preparar bromuro de amidoalquil-trifenil-fosfonio.
ES430416A Expired ES430416A1 (es) 1972-06-07 1974-09-26 Procedimiento para preparar derivados de prostaglandina.

Country Status (24)

Country Link
JP (2) JPS5715591B2 (xx)
AR (1) AR207434A1 (xx)
AT (1) AT340069B (xx)
BE (1) BE800580A (xx)
CA (1) CA985280A (xx)
CH (3) CH593929A5 (xx)
CS (1) CS200166B2 (xx)
DD (2) DD109211A5 (xx)
DE (1) DE2329092A1 (xx)
ES (3) ES415611A1 (xx)
FI (1) FI58327C (xx)
FR (2) FR2187344B1 (xx)
GB (2) GB1439512A (xx)
HU (3) HU170491B (xx)
IE (1) IE38058B1 (xx)
IL (2) IL42385A (xx)
IN (1) IN138966B (xx)
LU (1) LU67754A1 (xx)
NL (2) NL160814C (xx)
NO (2) NO146538C (xx)
PH (2) PH14204A (xx)
SE (3) SE415883B (xx)
YU (1) YU36498B (xx)
ZA (1) ZA733763B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3291E (es) * 1975-04-23 1980-08-22 Upjohn Co Procedimiento para preparar analogos de prostaglandinas
US6395787B1 (en) * 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3187043A (en) * 1962-05-18 1965-06-01 Monsanto Co Monohalophosphonium halides

Also Published As

Publication number Publication date
IN138966B (xx) 1976-04-17
CA985280A (en) 1976-03-09
SE415883B (sv) 1980-11-10
ZA733763B (en) 1974-04-24
NL7307867A (xx) 1973-12-11
ATA504873A (de) 1977-03-15
DD115687A5 (xx) 1975-10-12
PH13092A (en) 1979-11-27
NO740850L (no) 1973-12-10
NO146538B (no) 1982-07-12
GB1439512A (en) 1976-06-16
NL160814B (nl) 1979-07-16
CS200166B2 (en) 1980-08-29
LU67754A1 (xx) 1973-12-14
YU152673A (en) 1982-02-25
HU170200B (xx) 1977-04-28
NO142784C (no) 1980-10-15
AU5643173A (en) 1974-12-05
DE2329092A1 (de) 1974-01-03
DD109211A5 (xx) 1974-10-20
IE38058L (en) 1973-12-07
HU170491B (xx) 1977-06-28
PH14204A (en) 1981-04-01
GB1439511A (en) 1976-06-16
JPS5715591B2 (xx) 1982-03-31
JPS4954350A (xx) 1974-05-27
SE7608224L (sv) 1976-07-19
BE800580A (fr) 1973-12-07
FR2273814B1 (xx) 1977-07-08
NO146538C (no) 1982-10-20
ES430416A1 (es) 1976-10-16
FR2187344B1 (xx) 1977-10-28
CH591511A5 (xx) 1977-09-30
CH605887A5 (xx) 1978-10-13
ES430417A1 (es) 1977-03-01
IE38058B1 (en) 1977-12-21
AT340069B (de) 1977-11-25
NL160814C (nl) 1979-12-17
AR207434A1 (es) 1976-10-08
CH593929A5 (xx) 1977-12-30
IL51525A0 (en) 1977-04-29
FI58327C (fi) 1981-01-12
NL7812163A (nl) 1979-04-27
FI58327B (fi) 1980-09-30
IL42385A0 (en) 1973-07-30
IL42385A (en) 1979-10-31
FR2273814A1 (fr) 1976-01-02
SE418744B (sv) 1981-06-22
HU170487B (xx) 1977-06-28
FR2187344A1 (xx) 1974-01-18
JPS5731692A (en) 1982-02-20
SE7608225L (sv) 1976-07-19
NO142784B (no) 1980-07-07
YU36498B (en) 1984-02-29

Similar Documents

Publication Publication Date Title
SE323866B (xx)
ES415611A1 (es) Un procedimiento para preparar una prostaglandina.
ES434304A1 (es) Procedimiento para preparar esteres del acido dihidro-16,17apovincaminico.
ES408615A1 (es) Procedimiento para la preparacion de 4-amino-3,5-dihalogenofenil - etanolaminas.
ES323226A1 (es) Un procedimiento para obtener un ester del acido ciclopropanocarboxilico.
GB1424416A (en) Prostaglandin intermediates and their preparation
GB1311438A (en) Lincomycin derivatives and the preparation thereof
ES421713A1 (es) Procedimiento para la preparacion de derivados de acido pregnanico.
ES405648A1 (es) Procedimiento para la preparacion de nuevos acidos 4 - (4 -bifenilil) - 4 - hidroxi - butiricos, sus esteres o lacto- nas.
ES385419A1 (es) Procedimiento de preparacion de nuevos derivados de acido tiofeno-acetico.
ES301503A1 (es) Un procedimiento para la preparaciën de un compuesto derivado del acido nicotinico
GB1107234A (en) Production of acrylate and methacrylate esters
ES344179A1 (es) Procedimiento para la preparacion de derivados del flavano.
ES390720A1 (es) Procedimiento de preparacion de nuevos derivados de la ci- clopentanona.
ES395599A1 (es) Procedimiento para la preparacion de nuevos acidos 3 - (3- acilamino-2,4,6-triyodo-fenoxi)-alcoxi) - 2 - alcohil - pro-pionicos, utilizables como componentes suministradores de sombra en agentes de contraste de rayos x.
ES406129A1 (es) Procedimiento para la preparacion de 4 - (4 - bifenilil) - butiricos y sus esteres.
GB1416040A (en) Proces for the preparation of 3-mono-alkyl and 3,6-dialkyl -resorcylic esters
ES410418A1 (es) Un procedimiento para la preparacion de nuevos derivados deacidos xanton-2-carboxilicos.
ES385084A1 (es) Un procedimiento para la preparacion de nuevos derivados deacido glucuronico.
ES342910A1 (es) Procedimiento para la preparacion de hidroxiacidos.
GB1365316A (en) Processes for preparing prostaglandins
GB1045544A (en) New derivatives of pyrazolidines their production and use
GB1088621A (en) Improvements in or relating to podophyllin derivatives
ES423975A1 (es) Procedimiento para la preparacion de nuevas bencilaminas.
GB1107036A (en) Esters of dibenzocycloheptenyl-carboxylic acids